Compositions comprising dexamethasone
A pharmaceutical composition useful for the treatment of multiple myeloma in combination with an anti-cancer drug is provided. The pharmaceutical composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof.
1. A high-dose immediate release dexamethasone tablet or caplet for oral administration in the form of a single unit dosage form consisting of:
i) 20 mg dexamethasone,
ii) 4 mg to 8 mg sodium carboxymethyl starch,
iii) 48 mg to 58 mg lactose,
iv) 12.5 mg to 22.5 mg starch,
v) 2.5 mg polyvinylpyrrolidone, and
vi) 0.5 mg to 1.5 mg magnesium stearate,
wherein the unit dosage form has a total weight of about 100 mg.
2. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , which is uncoated.
3. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , having a hardness value of about 40 N to about 100 N.
4. The high-dose immediate release dexamethasone tablet or caplet of claim 3 , having a hardness value of about 47 N to about 73 N.
5. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , having a friability of about 0.05% to about 0.5%.
6. The high-dose immediate release dexamethasone tablet or caplet of claim 5 , having a friability of about 0.08% to about 0.22%.
7. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , containing 51 mg to 55 mg lactose.
8. The high-dose immediate release dexamethasone tablet or caplet of claim 7 , wherein the lactose is lactose monohydrate.
9. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , containing 20 mg dexamethasone, 58 mg lactose monohydrate, 6 mg sodium carboxymethyl starch, 12.5 mg corn starch, 2.5 mg polyvinylpyrrolidone, and 1 mg magnesium stearate, wherein the unit dosage form has a total weight of about 100 mg.
10. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , containing 20 mg dexamethasone, 53 mg lactose monohydrate, 6 mg sodium carboxymethyl starch, 17.5 mg corn starch, 2.5 mg polyvinylpyrrolidone, and 1 mg magnesium stearate, wherein the unit dosage form has a total weight of about 100 mg.
11. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , containing 20 mg dexamethasone, 48 mg lactose monohydrate, 6 mg sodium carboxymethyl starch, 22.5 mg corn starch, 2.5 mg polyvinylpyrrolidone, and 1 mg magnesium stearate, wherein the unit dosage form has a total weight of about 100 mg.
12. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , containing 20 mg dexamethasone, 55 mg lactose monohydrate, 4 mg sodium carboxymethyl starch, 17.5 mg corn starch, 2.5 mg polyvinylpyrrolidone, and 1 mg magnesium stearate, wherein the unit dosage form has a total weight of about 100 mg.
13. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , containing 20 mg dexamethasone, 51 mg lactose monohydrate, 8 mg sodium carboxymethyl starch, 17.5 mg corn starch, 2.5 mg polyvinylpyrrolidone, and 1 mg magnesium stearate, wherein the unit dosage form has a total weight of about 100 mg.
14. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , containing 20 mg dexamethasone, 53.5 mg lactose monohydrate, 6 mg sodium carboxymethyl starch, 17.5 mg corn starch, 2.5 mg polyvinylpyrrolidone, and 0.5 mg magnesium stearate, wherein the unit dosage form has a total weight of about 100 mg.
15. The high-dose immediate release dexamethasone tablet or caplet of claim 1 , containing 20 mg dexamethasone, 52.5 mg lactose monohydrate, 6 mg sodium carboxymethyl starch, 17.5 mg corn starch, 2.5 mg polyvinylpyrrolidone, and 1.5 mg magnesium stearate, wherein the unit dosage form has a total weight of about 100 mg.